SCHEMBL23439722

SCHEMBL23439722

N/C(=C\C=C(/N)N1CCCC1)c1cccc(C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.48
KDM4E B2RXH2 3/20 0.48
GAA P10253 3/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
HSD17B10 Q99714 2/20 0.48
L3MBTL3 Q96JM7 1/20 0.46
MAPT P10636 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
HIF1A Q16665 1/20 0.43
IL1RN P18510 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 3/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23440129 0.82 F2 (0.41) HPGDKDM4EALDH1A1MAPTPARP1
SCHEMBL23440438 0.81 RAB9A (0.49) ALDH1A1KMT2AMAPTNPC1RAB9A
Isophthalic Acid SCHEMBL5406230 0.80 HPGD (0.57) HPGDKDM4EGAAALDH1A1MEN1
SCHEMBL23440353 0.79 PARP1 (0.44) HPGDALDH1A1MEN1KMT2APOLB
Isophthalic Acid SCHEMBL5411490 0.79 HPGD (0.56) HPGDKDM4EGAAALDH1A1MEN1
Isophthalic Acid SCHEMBL27899309 0.76 HPGD (0.61) HPGDKDM4EGAAALDH1A1MEN1
SCHEMBL23440152 0.75 MAPK1 (0.56) HPGDKDM4EGAAALDH1A1KMT2A
SCHEMBL4696934 0.75 L3MBTL3 (0.72) HPGDKDM4EGAAALDH1A1MEN1
SCHEMBL15076720 0.73 L3MBTL3 (0.70) HPGDKDM4EGAAALDH1A1MEN1
SCHEMBL23439710 0.73 ALDH1A1 (0.39) HPGDALDH1A1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105906-A1 ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE GAIN THERAPEUTICS SA (CH) 2021-06-03 WO disclosed